Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-02-Speech-3-290-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110202.19.3-290-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"We must combat tuberculosis, because this disease kills nearly two million people worldwide each year, and almost a third of the world’s population is infected by it. I would like to draw attention to the fact that tuberculosis is a sensitive world health issue and the second greatest cause of death among infectious diseases worldwide. Tuberculosis is heavily linked to social and economic problems, such as poverty, unemployment, alcoholism, drug addiction and HIV/AIDS, as well as the inadequate and poor state of healthcare systems in poor countries and delays in diagnosis. I am therefore pleased that the Tuberculosis Vaccine Initiative model has been drawn up, because all patients suffering from tuberculosis worldwide will be able to benefit from the results of research and work activities. Furthermore, this project would contribute towards implementing the Europe 2020 objectives and achieving the Millennium Development Goals by 2015. I would like to point out that there is insufficient funding for the fight against tuberculosis and European Union funding is very important for establishing a strong package of new potential tuberculosis vaccines. I hope that progress will be made as soon as possible to licence current potential European tuberculosis vaccines, and that they will be available to those who most need them. Furthermore, it is important to find opportunities to implement competitive funding mechanisms to carry out the final stages of clinical research into new vaccines against tuberculosis."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples